Eric Richman, Director at Altimmune, holds 63.83K shares in NeuBase Therapeutics (Ticker: NBSE), holds 44.03K shares in ADMA Biologics (Ticker: ADMA), holds 186.82K shares in Altimmune (Ticker: ALT). Most recently, Eric Richman Bought ― shares of NeuBase Therapeutics on May 04, 2020 for an estimated value of 65.00K.
What is the percentage of profitable transactions made by Eric Richman?
The percentage of profitable transactions made by Eric Richman is 42%.
What is the average return per transaction made by Eric Richman?
The average return per transaction made by Eric Richman is 32.90%.
What stocks does Eric Richman hold?
Eric Richman holds: ALT, NBSE, ADMA stocks.
What was Eric Richman’s latest transaction?
Eric Richman latest transaction was an Informative Buy of $65.00K.
What was Eric Richman's most profitable transaction?
Eric Richman’s most profitable transaction was an Informative Buy of ALT stock on April 11, 2016. The return on the trade was 199.80%.
What is Eric Richman's role in Altimmune?
Eric Richman's role in Altimmune is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.